Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells

European Journal of Cancer

Volumn 45, Issue 5, 2009, Pages 874-880

  Glienke, Wolfgang ^a   Maute, Luise ^a   Wicht, Johannes ^a   Bergmann, Lothar ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Curcumin; Pancreatic cancer; siRNA; WT1

Indexed keywords

CURCUMIN; MESSENGER RNA; SMALL INTERFERING RNA; WT1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; GENE; GENE TARGETING; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILMS TUMOR GENE 1;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, WILMS TUMOR; HUMANS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 61349105913     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.12.030     Document Type: Article

References (42)

1. Rosewicz S., and Wiedenman B. Pancreatic carcinoma. Lancet 349 (1997) 485-489
2. Michaud D.S. Epidemiology of pancreatic cancer. Minerva Chir 59 (2004) 99-111
3. Lowenfels A.B., and Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20 (2006) 197-209
4. Kunnumakkara A., Anand P., and Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269 (2008) 199-225
5. Dhillon N., Aggarwal B.B., Newman R.A., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14 (2008) 4491-4499
6. Call K.M., Glaser T., Ito C.Y., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60 (1990) 509-520
7. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., and Bruns G.A.P. Homozygous deletion in Wilms' tumours of a gene identified by chromosome jumping. Nature 343 (1990) 774-778
8. Rauscher F.J., Morris J.F., Tournay O.E., Cook D.M., and Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250 (1990) 1259-1262
9. Hamilton T.B., Barilla K.C., and Romaniuk P.J. High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucleic Acids Res 23 (1995) 277-284
10. Anuchapreeda S., Limtrakul P., Thanarattanakorn P., Sittipreechacharn S., and Chanarat P. Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells. Arch Pharm Res 29 (2006) 80-87
11. Anuchapreeda S., Thanarattanakorn P., Sittipreechacharn S., Chanarat P., and Limtrakul P. Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta Pharmacol Sin 27 (2006) 360-366
12. Anuchapreeda S., Tima S., Duangrat C., and Limtrakul P. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol 62 (2008) 585-594
13. Inoue K., Sugiyama H., Ogawa H., et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84 (1994) 3071-3079
14. Bergmann L., Miething C., Maurer U., et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90 (1997) 1217-1225
15. Oji Y., Miyoshi S., Maeda H., et al. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100 (2002) 297-303
16. Loeb D.M., Evron E., Patel C.B., Sharma P.M., Niranjan B., Buluwela L., Weitzman S.A., Korz D., and Sukumar S. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61 (2001) 921-925
17. Miyoshi Y., Ando A., Egawa C., et al. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8 (2002) 1167-1171
18. Oji Y., Yamamoto H., Nomura M., et al. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 94 (2003) 712-717
19. Oji Y., Miyoshi Y., Koga S., et al. Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer. Cancer Sci 94 (2003) 606-611
20. Oji Y., Inohara H., Nakazawa M., et al. Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma. Cancer Sci 94 (2003) 523-529
21. Barbolina M.V., Adley B.P., Shea L.D., and Stack M.S. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 112 (2008) 1632-1641
22. Oji Y., Nakamori S., Fujikawa M., et al. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci 95 (2004) 583-587
23. Nakatsuka S., Oji Y., Horiuchi T., et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Modern Pathol 19 (2006) 804-814
24. Oka Y., Tsuboi A., Oji Y., Kawase I., and Sugiyama H. WT1 peptide vaccine for the treatment of cancer. Curr Opin Immunol 20 (2008) 211-220
25. Ueda T., Oji Y., Naka N., et al. Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci 94 (2003) 271-276
26. Yamagami T., Sugiyama H., Inuoe K., et al. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87 (1996) 2878-2884
27. Algar E.M., Khromykh T., Smith S.I., Blackburn D.M., Bryson G.J., and Smith P.J. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12 (1996) 1005-1014
28. Oji Y., Ogawa H., Tamaki H., et al. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90 (1999) 194-204
29. Hübinger G., Schmid M., Linortner S., Manegold A., Bergmann L., and Maurer U. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. Exp Hematol 29 (2001) 1226-1235
30. Elmaagacli A.H., Koldehoff M., Peceny R., et al. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica 90 (2005) 326-334
31. Glienke W., Maute L., Koehl U., Esser R., Milz E., and Bergmann L. Effective treatment of leukemic cell lines with wt1 siRNA. Leukemia 21 (2007) 2164-2170
32. Anand P., Kunnumakkara A., Newman R.A., and Aggarwal B.B. Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 4 (2007) 807-818
33. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 57 (2007) 43-66
34. Khanbolooki S., Nawrocki S.T., Arumugam T., et al. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther 5 (2006) 2251-2260
35. Mackenzie G.G., Queisser N., Wolfson M.L., Fraga C.G., Adamo A.M., and Oteiza P.I. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer 123 (2008) 56-65
36. Cilloni D., Messa F., Gottardi E., et al. Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation. Cancer 101 (2004) 979-988
37. Rong Y., Cheng L., Ning H., et al. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res 66 16 (2006) 8049-8057
38. Buettner R., Mora L.B., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8 (2002) 945-954
39. Schindler C., and Darnell J.E.J. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64 (1995) 621-651
40. Wen Z., Zhong Z., and Darnell J.E.J. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
41. Wen Z., and Darnell J.E.J. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucl Acids Res 25 (1997) 2062-2067
42. Fukada T., Ohtani T., and Yoshida Y. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 17 (1998) 6670-6677